State NJ
Clinical Trials in New Jersey
Recruiting clinical trials with at least one study location in New Jersey. Data updated daily from ClinicalTrials.gov.
Top Conditions in New Jersey
NCT04775537 N/A
Recruiting
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Condition
Spinal Disease
Enrollment
120 pts
Location
United States
Sponsor
Collagen Matrix
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07063212 Phase 2
Recruiting
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With He...
Condition
Squamous Cell Carcinoma of Head and Neck
Enrollment
40 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07309029 N/A
Recruiting
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
Condition
Severe Aortic Stenosis
Enrollment
30 pts
Location
United States
Sponsor
Atlantic Health System
NCT06676592 N/A
Recruiting
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
Condition
Surgery
Enrollment
27 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06637644 N/A
Recruiting
Impella RP Flex with Smart Assist
Condition
Right Ventricular (RV) Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Abiomed Inc.
NCT06349434 N/A
Recruiting
The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremi...
Condition
SCI - Spinal Cord Injury
Enrollment
60 pts
Location
United States
Sponsor
Kessler Foundation
NCT04929899 N/A
Recruiting
Bright Ideas - CIN Feasibility Study
Condition
Acute Lymphoblastic Leukemia (ALL)
Enrollment
75 pts
Location
United States, Canada
Sponsor
The Hospital for Sick Children
NCT05126277 Phase 3
Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With ...
Condition
Lupus Nephritis
Enrollment
462 pts
Location
United States, Argentina, Brazil
Sponsor
Novartis Pharmaceuticals
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT05050136 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixib...
Condition
Primary Biliary Cholangitis
Enrollment
260 pts
Location
United States, Argentina, Belgium
Sponsor
Mirum Pharmaceuticals, Inc.
NCT05296421 N/A
Recruiting
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
16 pts
Location
United States
Sponsor
Rutgers, The State University
NCT06841354 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Comb...
Condition
Triple Negative Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06660394 Phase 3
Recruiting
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults ...
Condition
Dravet Syndrome
Enrollment
160 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT06749457 Phase 1, Phase 2
Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase...
Condition
Staphylococcus Aureus
Enrollment
231 pts
Location
United States
Sponsor
AstraZeneca
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04372277 Phase 4
Recruiting
Taltz in Combination With Enstilar for Psoriasis
Condition
Psoriasis
Enrollment
25 pts
Location
United States
Sponsor
Psoriasis Treatment Center of
NCT05721781 N/A
Recruiting
Reducing Risk for Infective Endocarditis
Condition
Bacteremia
Enrollment
320 pts
Location
United States
Sponsor
Wake Forest University Health
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
NCT05862272 Phase 3
Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugoli...
Condition
Uterine Fibroids
Enrollment
1,000 pts
Location
United States
Sponsor
Sumitomo Pharma Switzerland Gm
NCT07015242 Phase 2
Recruiting
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as Fir...
Condition
Lymphoma
Enrollment
65 pts
Location
United States, France, Germany
Sponsor
Juno Therapeutics, Inc., a Bri
NCT03672266 N/A
Recruiting
Studies of Brain and Body Interaction
Condition
Autistic Disorders Spectrum
Enrollment
100 pts
Location
United States
Sponsor
Rutgers University
NCT06066346 Phase 2
Recruiting
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA C...
Condition
Multiple Myeloma
Enrollment
17 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07449195 N/A
Recruiting
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular...
Condition
Ocular Tumor
Enrollment
60 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance